New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 26, 2012
06:11 EDTUBS, FLO, GSK, NOK, SIOn the Fly: Periodicals Wrap-Up
WALL STREET JOURNAL: Switzerland and the U.K. announced punitive measures against UBS (UBS) following the unauthorized trading scandal that led to losses of $2.3B at the bank. Swiss financial market regulator Finma said it will watch UBS's investment bank for the foreseeable future and may ask it to raise fresh capital, while the U.K. Financial Services Authority fined UBS $47.6M, the Wall Street Journal reports...Flowers Foods (FLO) could be interested in Twinkies and other products owned by Hostess Brands, and is considered a likely bidder for some of the assets owned by Hostess, the Wall Street Journal reports...REUTERS: The euro zone finance ministers and the IMF will seek to unfreeze the second bailout package for Greece today, but first need to agree if some of the official loans might eventually be forgiven to cut Greek debt, Reuters reports...GlaxoSmithKline (GSK) has no plans to delist its Indian consumer products arm GlaxoSmithKline Consumer Healthcare, said David Redfern, chief strategy officer, Reuters reports...BLOOMBERG: Home equity lines of credit that fueled a spending spree during the U.S.property boom are back. Following six years of declines, lending for so-called Helocs will increase 30% to $79.6B this year, the highest level since the start of the 2008 financial crisis, according to the economics research unit of Moody’s Corp. It projects a 31% jump to $104B next year, Bloomberg reports...Nokia Siemens Networks (NOK, SI) is targeting the U.S. market where Chinese rivals face political hurdles and rising data use entices carriers to spend. The venture is forgoing less lucrative deals in Africa and the Middle East, said CEO Rajeev Suri, Bloomberg reports.
News For UBS;FLO;GSK;NOK;SI From The Last 14 Days
Check below for free stories on UBS;FLO;GSK;NOK;SI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
August 31, 2014
14:04 EDTGSKWorldwide Business Research to hold a conference
Subscribe for More Information
August 29, 2014
11:23 EDTNOKNokia enters licensing agreement with Samsung, releases HERE for Android
Subscribe for More Information
August 28, 2014
13:56 EDTNOKNokia Here division teases 'Here for Gear' announcement for tomorrow
Subscribe for More Information
07:34 EDTGSKGSK could start testing Ebola vaccine on humans next week, Bloomberg reports
GlaxoSmithKline could begin tests of its experimental vaccine for Ebola on humans as early as next week in the U.S., Bloomberg reports. GSK is developing the vaccine with the Vaccine Research Center of the National Institutes of Health, and they have received FDA approval to begin the Phase 1 trial, Michael Kurilla, director of the Office of Biodefense, Research Resources and Translational Research, says. Reference Link
07:29 EDTNOKNokia removed from Europe 1 List at BofA/Merrill
06:35 EDTUBSEuro zone credit crunch showing signs of improving, Reuters says
Loans to the private sector by euro zone banks dropped 1.6% in July versus the same period a year earlier, compared with a year-over-year decline of 1.8% in June, according to Reuters. Meanwhile, the bloc's M3 money supply increased at a 1.8% annual rate in July, versus 1.6% in June, the news service added. The upturn in the data comes after the European Central Bank started charging banks in June to keep their deposits overnight, Reuters added. Publicly traded euro zone banks include Banco Santander (SAN), Barclays (BCS), Credit Suisse (CS), Deutsche Bank (DB), HSBC (HSBC), ING Groep (ING), Lloyds Banking (LYG), Royal Bank of Scotland (RBS) and UBS (UBS). Reference Link
August 27, 2014
17:49 EDTGSKGSK, Shire rumored to be interested in Tekmira, Daily Mail says
GlaxoSmithKline (GSK) and Shire (SHPG) are rumored to be interested in a bid for Tekmira (TKMR), reports Daily Mail. Tekmira could be a value to potential suitors, capitalized at approximately GBP 400M and the company could cost over GBP 1B in a takeover, Daily Mail adds. Reference Link
08:03 EDTGSKGlaxoSmithKline receives FDA approval for sNDA for Promacta/Revolade
Ligand Pharmaceuticals Incorporated (LGND) announced that its partner GlaxoSmithKline (GSK) has received approval of a supplemental New Drug Application for the once-daily use of Promacta/Revolade in patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy. SAA is a blood disorder where the bone marrow fails to make enough red blood cells, white blood cells and platelets.2 Eltrombopag, an oral thrombopoietin receptor agonist, works by helping to induce proliferation and differentiation of bone marrow stem cells to increase production of blood cells.
August 26, 2014
14:42 EDTGSKGlaxoSmithKline receives FDA approval of additional Promacta indication
Subscribe for More Information
08:47 EDTGSKGenetic Technologies says NC court denies GlaxoSmithKline motion to dismiss
Subscribe for More Information
August 25, 2014
19:58 EDTNOKRoyalty cap for Nokia, Microsoft deal may be ordered by S. Korea, Bloomberg says
The Fair Trade Commission of South Korea may implement a cap on royalty fees for Nokia (NOK) patents as a condition when they hold a meeting next month to approve the Microsoft (MSFT), Nokia deal, Bloomberg reports, citing the Seoul Economic Daily. Reference Link
12:19 EDTGSKOn The Fly: Midday Wrap
Subscribe for More Information
10:40 EDTGSKBiotechs rise after InterMune acquired by Roche
Subscribe for More Information
August 22, 2014
14:19 EDTGSKViiV Healthcare receives FDA approval for HIV-1 treatment Triumeq
Subscribe for More Information
August 21, 2014
05:52 EDTNOKStocks with implied volatility movement; NOK WLT
Stocks with implied volatility movement; Nokia (NOK) 30, Walter Energy (WLT) 62 according to iVolatility.
August 20, 2014
15:35 EDTGSKGlaxoSmithKline receives FDA approval for Arnuity Ellipta in the U.S.
Subscribe for More Information
11:44 EDTGSKMylan completes second bidding round for GSK prescription portfolio, WSJ says
Mylan (MYL), TPG Capital, Advent International, KKR (KKR), Warburg Pincus and a few Indian prescription manufacturers have completed the second round of bidding for GlaxoSmith Kline's (GSK) portfolio of mature medications, according to The Wall Street Journal, citing people familiar with the sales process. GSK noted that it aims to sell a portfolio of drug brands in the U.S. and EU with yearly sales of approximately $1.66B. Reference Link
08:30 EDTGSKPernix closes acquisition of Treximet
Subscribe for More Information
08:29 EDTGSKPernix Therapeutics to host conference call
Conference call to discuss acquisition of Treximet will be held on August 20 at 9 am. Webcast Link
08:04 EDTGSKPOZEN announces U.S. rights for Treximet acquired by Pernix Therapeutics
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use